You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cellular immunotherapy

Showing 1 - 25 of 6,052
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Septic Shock, Sepsis, Pathologic Processes Trial (Allogeneic umbilical cord-derived human mesenchymal stromal cells, Placebo)

Not yet recruiting
  • Septic Shock
  • +6 more
  • Allogeneic umbilical cord-derived human mesenchymal stromal cells
  • Placebo
  • (no location specified)
Aug 3, 2023

Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and Stroke (NINDS)

Completed
  • Progressive Multifocal Leukoencephalopathy
  • PyVST
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Cholangiocarcinoma Trial in Beijing (autologous Tcm cellular immunotherapy)

Recruiting
  • Cholangiocarcinoma
  • autologous Tcm cellular immunotherapy
  • Beijing, China
    Peking Union Medical College Hospital
Apr 24, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Mar 28, 2023

Recipients Who Previously Received Medeor's Cellular

Recruiting
  • Immune Tolerance
  • MDR product
  • New Haven, Connecticut
    Yale University
Apr 18, 2022

Following Treatment With Fate Therapeutics' Engineered Cellular

Terminated
  • Hematological Malignancy
  • Genetically engineered NK cells
  • Phoenix, Arizona
  • +4 more
Aug 24, 2022

Kidney Transplant Rejection Trial (MDR-103)

Not yet recruiting
  • Kidney Transplant Rejection
  • MDR-103
  • (no location specified)
Apr 4, 2022

Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)

Not yet recruiting
  • Kidney Transplant Rejection
  • MDR-102
  • Immunosuppressive Agents
  • (no location specified)
Apr 4, 2022

COVID-19 Trial in Vandœuvre-lès-Nancy (Generation of a biobank allowing the cryopreservation of leucocytes from COVID19

Not yet recruiting
  • COVID-19
  • Generation of a biobank allowing the cryopreservation of leucocytes from COVID19 convalescent donors
  • Vandœuvre-lès-Nancy, Lorraine, France
    CHRU-Nancy - Hopitaux de Brabois - Batiment Philippe Canton
Aug 17, 2022

Urinary Bladder Tumor Trial in Beijing (autologous Tcm cells immunotherapy)

Terminated
  • Urinary Bladder Neoplasm
  • autologous Tcm cells immunotherapy
  • Beijing, China
    Huanxing ward, Cancer Hospital Chinese Academy of Medical Scienc
Nov 19, 2021

Collection of Peripheral Blood Mononuclear Cells by Means of Apheresis Trial in Nanjing (collection of peripheral blood

Terminated
  • Collection of Peripheral Blood Mononuclear Cells by Means of Apheresis
  • collection of peripheral blood mononuclear cells from healthy volunteers
  • Nanjing, Jiangsu, China
    Hematological Department, People's Hospital of Jiangsu Province
Dec 17, 2021

Mantle Cell Lymphoma, Diffuse Large Cell Lymphoma, Burkitts Lymphoma Trial in Providence (cellular immunotherapy)

Terminated
Has Results
  • Mantle Cell Lymphoma
  • +4 more
  • cellular immunotherapy
  • Providence, Rhode Island
  • +1 more
Feb 23, 2022

Kidney Transplant Rejection Trial in Canada, United States (MDR-101)

Active, not recruiting
  • Kidney Transplant Rejection
  • MDR-101
  • La Jolla, California
  • +19 more
Aug 22, 2022

Healthy Subject Trial in Shanghai (Peripheral blood mononuclear cell apheresis)

Recruiting
  • Healthy Subject
  • Peripheral blood mononuclear cell apheresis
  • Shanghai, China
    Zhaxin Hospital of Integrated Traditional Chinese and Western Me
Jun 7, 2021

Long-term, Non-interventional, Observational Study Following

Recruiting
  • Advanced Solid Tumor
  • +17 more
  • Allogeneic natural killer (NK) cell
  • San Diego, California
  • +3 more
Oct 15, 2021

Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Anti-CD33 CAR T-cells
  • Lymphodepletion Therapy
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Metastatic Cancer, Metastatic Breast Cancer, Metastatic Lung Cancer Trial in Mexico City (SV-101)

Recruiting
  • Metastatic Cancer
  • +3 more
  • Mexico City, Mexico
    Hospital Diomed
Sep 14, 2022

Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte

Recruiting
  • Malignant Neoplasm
  • +4 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • Duarte, California
    City of Hope Medical Center
Sep 14, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Mexico City (SV-102)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Mexico City, Mexico
    Hospital Diomed
Sep 14, 2022

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent DLBCL Trial in Seattle (biological,

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +20 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 11, 2022

B Cell Leukemia Trial in Seattle (Autologous CD19 CAR+ EGFTt + T cells)

Active, not recruiting
  • B Cell Leukemia
  • Autologous CD19 CAR+ EGFTt + T cells
  • Seattle, Washington
    Seattle Children's Hospital
Feb 15, 2022

Hepatocellular Carcinoma Trial in Beijing (adoptive immunotherapy, MWA)

Completed
  • Hepatocellular Carcinoma
  • adoptive immunotherapy
  • MWA
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Mar 2, 2021

Malignant Brain Tumor, Recurrent Malignant Brain Tumor, Refractory Malignant Brain Tumor Trial in Duarte (Cyclophosphamide,

Recruiting
  • Malignant Brain Neoplasm
  • +2 more
  • Duarte, California
    City of Hope Medical Center
May 19, 2022

Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

Terminated
Has Results
  • Merkel Cell Polyomavirus Infection
  • Stage IV Merkel Cell Carcinoma AJCC v7
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 25, 2022

Diffuse Large-Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma (PMBCL), Transformed Follicular Lymphoma (TFL) Trial in

Recruiting
  • Diffuse Large-Cell Lymphoma
  • +3 more
  • Pneumococcal conjugate vaccine (PCV13)
  • CD19 targeted CAR T Cell Therapy
  • Tampa, Florida
    Moffitt Cancer Center
May 31, 2022